Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | PTGES | O14684 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28326632 | 0.98 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAMEN1MAPTKMT2A | |
| Acetic Acid SCHEMBL28983070 | 0.95 | LMNA (0.46) | SMN1; SMN2LMNAMEN1MAPTKMT2A | |
| SCHEMBL28326641 | 0.90 | DGKA (0.50) | SMN1; SMN2LMNAMEN1MAPTKMT2A | |
| SCHEMBL28326631 | 0.90 | SMN1; SMN2 (0.58) | SMN1; SMN2CYP1A2EPHX2EPHX1NAAA | |
| SCHEMBL4626998 | 0.89 | TDP1 (0.40) | SMN1; SMN2LMNAMEN1MAPTKMT2A | |
| SCHEMBL28326640 | 0.88 | DGKA (0.58) | SMN1; SMN2CYP1A2EPHX2NAAADGKA | |
| SCHEMBL28326652 | 0.88 | SMN1; SMN2 (0.56) | SMN1; SMN2CYP1A2EPHX2EPHX1NAAA | |
| SCHEMBL28878179 | 0.88 | DGKA (0.52) | SMN1; SMN2LMNAMEN1MAPTKMT2A | |
| SCHEMBL5710039 | 0.87 | DGKA (0.61) | SMN1; SMN2MAPTCYP1A2EPHX2NAAA | |
| SCHEMBL28157789 | 0.86 | MEN1 (0.51) | SMN1; SMN2LMNAMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111228155-A | Pet shampoo capable of lasting fragrance and preparation method thereof | 广州乐宠宠物用品有限公司 | 2020-06-05 | — | — | CN | claimed |
| CN-110300791-A | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter, and image display device | 东友精细化工有限公司 | 2019-10-01 | — | — | CN | claimed |
| CN-116035949-B | Oil balance type low-turbidity high-compatibility cosmetic composition | 广州科创材料科技有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-116035949-A | Oil balance type low-turbidity high-compatibility cosmetic composition | 上海永熙信息科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-110300791-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter, and image display device | 东友精细化工有限公司 | 2023-03-31 | — | — | CN | disclosed |
| EP-3694971-A1 | IMPROVEMENTS IN AND RELATING TO GARMENT REVIVAL | Unilever PLC (GB) | 2020-08-19 | — | — | EP | disclosed |
| CN-111228155-A | Pet shampoo capable of lasting fragrance and preparation method thereof | 广州乐宠宠物用品有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-110300791-A | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter, and image display device | 东友精细化工有限公司 | 2019-10-01 | — | — | CN | disclosed |
| CN-109843322-A | The inhibitor and its application method of indole amine 2,3-dioxygenase | 百时美施贵宝公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-109843293-A | The inhibitor and its application method of indole amine 2,3-dioxygenase | 百时美施贵宝公司 | 2019-06-04 | — | — | CN | disclosed |
| WO-2019073090-A1 | IMPROVEMENTS IN AND RELATING TO GARMENT REVIVAL | UNILEVER PLC (GB) | 2019-04-18 | — | — | WO | disclosed |
| WO-2011056935-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20090250371-A1 | Synergistically-Effective Composition of Zinc Ricinoleate and One or More Substituted Monocyclic Organic Compounds and Use Thereof For Preventing and/or Suppressing Malodors | NICOLL STEPHEN P | 2009-10-08 | — | — | US | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2008134712-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008070368-A2 | METHODS AND COMPOSITIONS FOR SKIN CARE | LIVING PROOF, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| EP-1447102-B1 | Cyclohexylethan-1-yl ester mixtures as malodour counteractants and methods for using same | INT FLAVORS & FRAGRANCES INC (US) | 2008-06-04 | — | — | EP | disclosed |
| US-20050106192-A1 | Synergistically-effective composition of zinc ricinoleate and one or more substituted monocyclic organic compounds and use thereof for preventing and/or suppressing malodors | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2005-05-19 | — | — | US | disclosed |
| EP-1447102-A1 | Cyclohexylethan-1-yl ester mixtures as malodour counteractants and methods for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2004-08-18 | — | — | EP | disclosed |
| US-20040156742-A1 | Synergistically-effective cyclohexylethan-1-yl ester mixtures as malodour counteractants as measured physiologically and psychometrically and methods for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | SMN1; SMN2 1562/4885LMNA 45/4885MEN1 1603/4885 |
| US-20050106192-A1 | Synergistically-effective composition of zinc ricinoleate and one or more substituted monocyclic organic compounds and use thereof for preventing and/or suppressing malodors | MAL2, ME1, MALT1 | SMN1; SMN2 2230/4885LMNA 2841/4885MEN1 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.